Pharma ETFs in Focus Post Q4 Earnings

The slew of Q4 results has led to mixed trading in pharma ETFs over the past 10 days. Here is a highlight of those in detail.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.